Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis)
Clinical trial NCT04236921 · COMPLETED
Trial details
- NCT number
- NCT04236921
- Sponsor
- Riverside Pharmacueticals Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2019-09-11
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.